Approval Letter for Clinical Trial Implementation
-
Micro, Small, and Medium Enterprises (UMKU) Details
Parameter: All
Authority: Minister/Head of the Agency
Requirements:-
Pre-Marketing Clinical Trial Authorization
1. Administrative Requirements
2. Technical Requirements
3. Non-Tax State Revenue (PNBP) Payment
Duration: -
-
Response Letter to Notification of Post-Marketing Clinical Trials
1. Administrative Requirements
2. Technical Requirements
3. Non-Tax State Revenue (PNBP) Payment
Duration: -
-
Pre-Marketing Clinical Trial Authorization
-
Obligations:
- Conducting Clinical Trials according to the approved protocol methodology and Good Clinical Practice (GCP) standards Duration: -
- Progress Report of Clinical Trial, at least every 6 months Duration: -
- Final Report of Clinical Trial, no later than 30 (thirty) working days after the completion of the clinical trial Duration: -
- Report of Premature Termination of Clinical Trial, no later than 15 (fifteen) working days after the termination of the clinical trial Duration: -
- Report of Adverse Events (AE) if any adverse events occur Duration: -
- Report of Changes/Amendments to Clinical Trial Documents in case of changes Duration: -
Sector: Health
Status: Not available
Belongs to:
32503
Need advice on setting up a company in Indonesia?
KBLI.co.id is a subsidiary of Emerhub, the largest independet corporate advisory firm in Indonesia.
![](/img/assistance.png)
Schedule a free consultation
Share your plans for Indonesia with us, and our advisors will recommend the most appropriate type and classification of legal entity for your needs.
![](/img/options.png)
No commitment required
We recognize that you might be in the exploratory phase of deciding whether and how to expand into Indonesia. Allow us to simplify this process for you.
![](/img/qualified.png)
Always credible information
Due to frequent changes in regulations and government policies, there is a prevalence of misleading and outdated advice. As we handle company registrations daily, we are well-informed about the most current information.